Prescribing pattern of antidiabetic drugs in gestational diabetes among adult pregnant women at Bugando Medical Centre, Mwanza, Tanzania
Material type:
TextPublisher number: Phone: +255 28 298 3384 Fax: +255 28 298 3386 Email: vc@bugando.ac.tz Website: www.bugando.ac.tz Language: English Language: Kiswahili Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] 11.05.2022Description: x; 23 Pages; Includes Refferences and AppendicesSubject(s): Summary: ABSTRACT:
Background: Gestational diabetes mellitus (GDM) defined as any degree of glucose intolerance with onset or first recognition during pregnancy. In 2010 there were estimated 22million women with diabetes between the age of 20 and 39 years. The global GDM prevalence estimates <1% -28% present of wide variation is due to, ethic variation among various population and consistent use of screening and diagnostic criteria.
Methodology: A retrospective cross-sectional study was conducted at Bugando Medical Centre on May 2022; sample size was obtained using Kish Leslie Formula 1965. The data regarding demographic details, gestation period glucose level and antidiabetics drugs were collected.
Results: A total of 115 pregnant women were involved in the study and all were in patients and all were diagnosed with gestational diabetes. The most prescribed antidiabetics drugs were Insulin injection 47.0%, Metformin 40.2% and Glyburide 4.3%. Also, the drugs were prescribed as monotherapy, followed by dual and lastly triple therapy.
Discussion: From the study it shows that gestational diabetes occurs during 21-30 weeks of pregnant and occurs mostly at the age group of 31-40.
Conclusion: The prescribing pattern of mono and dual therapy was high as compared to triple therapy; also, gestational diabetes mostly occurs in 21-30 weeks.
| Item type | Current library | Collection | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | CRECU/2316 | 1 | CRECU/2316 |
ABSTRACT:
Background: Gestational diabetes mellitus (GDM) defined as any degree of glucose intolerance with onset or first recognition during pregnancy. In 2010 there were estimated 22million women with diabetes between the age of 20 and 39 years. The global GDM prevalence estimates <1% -28% present of wide variation is due to, ethic variation among various population and consistent use of screening and diagnostic criteria.
Methodology: A retrospective cross-sectional study was conducted at Bugando Medical Centre on May 2022; sample size was obtained using Kish Leslie Formula 1965. The data regarding demographic details, gestation period glucose level and antidiabetics drugs were collected.
Results: A total of 115 pregnant women were involved in the study and all were in patients and all were diagnosed with gestational diabetes. The most prescribed antidiabetics drugs were Insulin injection 47.0%, Metformin 40.2% and Glyburide 4.3%. Also, the drugs were prescribed as monotherapy, followed by dual and lastly triple therapy.
Discussion: From the study it shows that gestational diabetes occurs during 21-30 weeks of pregnant and occurs mostly at the age group of 31-40.
Conclusion: The prescribing pattern of mono and dual therapy was high as compared to triple therapy; also, gestational diabetes mostly occurs in 21-30 weeks.
There are no comments on this title.
Click on an image to view it in the image viewer